PCOS 101: A Complete, Dietitian-Reviewed Guide to Polycystic Ovary Syndrome

What is PCOS?

Polycystic Ovary Syndrome (PCOS) is a chronic endocrine and metabolic condition affecting an estimated 8 to 13 percent of women of reproductive age worldwide. It is the most common cause of ovulatory infertility, the leading driver of androgen excess in women, and one of the strongest risk factors for type 2 diabetes, gestational diabetes, and cardiometabolic disease in women under 50. PCOS is also one of the most under-diagnosed and under-explained conditions in women's medicine: an estimated 70 percent of women who meet diagnostic criteria have not received a formal diagnosis.

The name "polycystic ovary syndrome" is somewhat misleading. The cysts the name refers to are not true cysts but immature follicles arrested in development. Many women with PCOS have ovaries that look normal on ultrasound, and many women with polycystic-appearing ovaries do not have PCOS. The condition is fundamentally a constellation of three features (androgen excess, ovulatory dysfunction, polycystic ovarian morphology), at least two of which must be present for diagnosis under the most widely used criteria.

The Rotterdam diagnostic criteria

The 2003 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop established the diagnostic standard now used by the Endocrine Society, the AE-PCOS Society, ACOG, and the 2023 International Evidence-based Guideline. PCOS is diagnosed when at least two of the following three are present, after exclusion of mimicking conditions (thyroid disease, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors):

1. Clinical or biochemical hyperandrogenism

Clinical: hirsutism (excess hair on the face, chest, back, abdomen), persistent acne, androgenic alopecia (hair thinning at the crown). Biochemical: elevated total or free testosterone, elevated free androgen index (FAI), elevated DHEA-S. The clinical signs alone are sufficient and do not require lab confirmation, though labs are commonly drawn to rule out other causes.

2. Ovulatory dysfunction

Defined as cycles longer than 35 days, fewer than 8 cycles per year, or absent menstruation for 3 or more months. Some women with PCOS have apparently regular cycles but are anovulatory (the cycle bleeds without ovulation), which can be confirmed with a mid-luteal progesterone test.

3. Polycystic ovarian morphology on ultrasound

20 or more follicles measuring 2 to 9 mm in either ovary, or an ovarian volume above 10 mL. The 2023 Guideline updated the threshold (previously 12 follicles) to reduce over-diagnosis in the era of higher-resolution ultrasound. Ultrasound is not required if the other two criteria are clearly met.

The four PCOS phenotypes

The Rotterdam criteria yield four distinct phenotypes, each with different metabolic risk profiles and different treatment priorities. Phenotype matters: it determines which interventions are most likely to work for you.

Phenotype A — the full triad (most common, highest metabolic risk)

Hyperandrogenism + ovulatory dysfunction + polycystic ovaries. Approximately 60 percent of diagnosed cases. Highest risk of insulin resistance, type 2 diabetes, and cardiometabolic complications. Most likely to benefit from insulin-sensitizing interventions (metformin, inositol, low-glycemic diet, resistance exercise).

Phenotype B — hyperandrogenism + ovulatory dysfunction (no polycystic ovaries)

Approximately 20 percent of cases. Similar metabolic risk profile to phenotype A but normal-appearing ovaries on ultrasound. Same management approach as phenotype A.

Phenotype C — hyperandrogenism + polycystic ovaries (regular cycles)

Approximately 10 percent of cases. Ovulatory PCOS. Lower metabolic risk than A and B but androgen excess still requires treatment for skin and hair symptoms. Often missed because cycles look normal.

Phenotype D — ovulatory dysfunction + polycystic ovaries (no hyperandrogenism)

Approximately 10 percent of cases. Often called "lean PCOS" though obesity rates are still elevated above general population. Lowest metabolic risk profile but still has fertility implications. Some experts disagree about whether phenotype D should be classified as PCOS at all.

PCOS symptoms: what is actually happening in your body

Insulin resistance and the metabolic engine

Insulin resistance is present in approximately 70 percent of PCOS phenotypes (lean and obese alike) and is the central metabolic driver of the condition for most women. When cells become resistant to insulin, the pancreas compensates by producing more of it. The resulting hyperinsulinemia has two ovarian consequences: it directly stimulates ovarian androgen production by theca cells, and it suppresses sex hormone-binding globulin (SHBG), which raises the proportion of testosterone that is biologically active. The result is the androgen excess that drives PCOS skin and hair symptoms and disrupts ovarian follicle development.

The hormonal cascade: cycle, androgen, prolactin

Excess androgens from the ovary (and to a lesser extent the adrenal gland) feed back to the hypothalamus and disrupt the pulsatile release of GnRH (gonadotropin-releasing hormone). This leads to elevated luteinizing hormone (LH) relative to follicle-stimulating hormone (FSH), which further pushes ovaries toward androgen production rather than estrogen production and ovulation. Follicles begin development but arrest before ovulating, accumulating as the small follicles seen on ultrasound. This is the hormonal loop PCOS treatment aims to break, either upstream (insulin sensitization) or downstream (anti-androgens, ovulation induction).

Skin, hair, weight, mental health

• Skin: persistent adult acne (especially jaw, chin, back), oily skin, acanthosis nigricans (velvety dark patches at neck, underarms, groin — a sign of insulin resistance).
• Hair: hirsutism (terminal hair growth in male-pattern locations) in 60-70 percent of PCOS women. Androgenic alopecia (thinning at the crown or temples) in approximately 20 percent. Conversely, some women have rapid leg, arm, or facial hair growth without classic male-pattern distribution.
• Weight: approximately 50-60 percent of PCOS women are overweight or obese, with central adiposity (more visceral fat than peripheral). Lean PCOS phenotypes still often carry more visceral fat than weight-matched controls.
• Mental health: rates of depression, anxiety, and disordered eating are 2-3 times higher in PCOS than in the general population. This is partly biological (insulin resistance, inflammation, and androgen excess all affect mood pathways) and partly the cumulative impact of living with the condition.

Why PCOS is so often misdiagnosed (or undiagnosed)

An estimated 70 percent of women who meet PCOS diagnostic criteria are undiagnosed. The reasons cluster:

1. Symptom variability across phenotypes. Lean PCOS, post-pill PCOS, and adrenal PCOS often present without the textbook obese-and-hirsute picture, and primary care providers may not consider the diagnosis.
2. Hormonal birth control masks symptoms. Combined oral contraceptives reduce androgens, regulate cycles, and clear acne. Women on the pill from adolescence often discover PCOS only when they stop the pill (sometimes years later trying to conceive).
3. Single-symptom dismissal. Women presenting with weight gain alone, irregular cycles alone, or acne alone are often treated symptomatically rather than worked up for an underlying cause.
4. Insufficient lab workup. Diagnosis ideally includes total testosterone, free androgen index, SHBG, fasting insulin and glucose (HOMA-IR), HbA1c, prolactin, TSH, 17-hydroxyprogesterone, and a pelvic ultrasound. Many women receive only a partial workup.
5. Provider awareness gaps. Despite affecting 1 in 8-10 women, PCOS receives a small fraction of medical curriculum time and research funding relative to its prevalence.

The PCOS Meal Planner pathways: 5 ways into the rest of this site

This guide is the entry point. From here, choose the pathway most relevant to your situation:

Insulin resistance pathway

If insulin resistance is the dominant driver of your PCOS (HOMA-IR above 2.5, fasting insulin above 10, or you have classic phenotype A or B), start with our Inositol vs Metformin evidence comparison and our why calorie restriction backfires in PCOS piece.

Symptom management pathway

If you're focused on skin, hair, and acne symptoms, start with our supplement deep-dives: Zinc for PCOS and the foods that reduce facial hair.

Nutrition fundamentals pathway

If you want to rebuild your eating around PCOS-aware principles, start with our complete PCOS grocery list, our PCOS breakfast ideas, and our PCOS food checker.

Fertility & hormones pathway

If you're trying to conceive, the inositol vs metformin comparison is the right starting point, plus the cycle-supportive nutrition principles in our best protein sources for PCOS piece.

Mental health & stress pathway

If anxiety, depression, or disordered eating patterns are part of your PCOS picture, the foundation pieces on cortisol management and gentle nutrition are key. Our editorial process describes how we approach this content with anti-restriction framing.

When to see a doctor and what tests to ask for

If you have any two of the following, ask your primary care provider, OB-GYN, or endocrinologist for a PCOS workup:

• Cycles longer than 35 days, fewer than 8 cycles per year, or absent periods for 3+ months (off birth control)
• Persistent adult acne, hirsutism, or hair thinning at the crown
• Difficulty losing weight despite reasonable diet and exercise
• Family history of PCOS or type 2 diabetes
• Acanthosis nigricans (dark velvety patches at neck or underarms)
• Difficulty conceiving after 6-12 months of trying

Lab and imaging panel to request:

• Hormones: total testosterone, free testosterone or free androgen index, SHBG, DHEA-S, LH, FSH, estradiol, prolactin, TSH, 17-hydroxyprogesterone (to rule out non-classic congenital adrenal hyperplasia)
• Metabolic: fasting glucose, fasting insulin (calculate HOMA-IR), HbA1c, lipid panel (total cholesterol, LDL, HDL, triglycerides), and ideally an oral glucose tolerance test
• Imaging: transvaginal pelvic ultrasound (or transabdominal if not sexually active) to assess ovarian morphology and rule out other pathology
• Optional follow-up: mid-luteal progesterone if cycles seem regular but ovulation is in question; vitamin D level

A note on PCOS and meal planning

Diet is the single most controllable lever for most women with PCOS. The core dietary principles supported by the 2023 International Evidence-based Guideline:

1. A modest energy deficit if weight loss is a clinical goal (not for everyone — phenotype D and lean PCOS often do not need calorie reduction).
2. Protein at 25 to 30 percent of energy intake (higher than typical Western diets).
3. Carbohydrates at 30 to 45 percent of energy, weighted toward low-glycemic, fiber-rich sources.
4. Anti-inflammatory fats (Mediterranean pattern) at 30 to 40 percent of energy.
5. Adequate fiber (25 to 35 grams per day) and adequate intake of magnesium, zinc, vitamin D, and omega-3s.
6. Resistance exercise 2 to 3 times per week plus moderate aerobic activity.

PCOS Meal Planner builds this into a personalized weekly meal plan automatically. Start a 7-day trial.

Frequently Asked Questions

Can PCOS be cured?

PCOS cannot be cured but symptoms — including insulin resistance, irregular cycles, and androgen excess — can be substantially improved with diet, exercise, and (in some cases) medication. Many women restore ovulatory function and resolve metabolic markers with sustained lifestyle change. The underlying genetic and endocrine predisposition remains, which is why ongoing management is part of PCOS rather than a one-time fix.

What are the 4 PCOS phenotypes?

Phenotype A is the full triad (hyperandrogenism + ovulatory dysfunction + polycystic ovaries) and accounts for 60 percent of cases with the highest metabolic risk. Phenotype B is hyperandrogenism + ovulatory dysfunction without polycystic ovaries. Phenotype C is hyperandrogenism + polycystic ovaries with regular cycles (ovulatory PCOS). Phenotype D is ovulatory dysfunction + polycystic ovaries without hyperandrogenism (lowest metabolic risk).

How is PCOS diagnosed?

PCOS is diagnosed using the Rotterdam criteria: at least two of three findings — clinical or biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology on ultrasound — and exclusion of mimicking conditions (thyroid disease, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors).

What is the difference between PCOS and PCOD?

PCOD (polycystic ovarian disease) is an older term still used in some regions, particularly India. The clinical definitions overlap but PCOS, defined by the Rotterdam criteria, is the term used by current US, UK, Australian, and international clinical guidelines.

Can you have PCOS with regular periods?

Yes. Phenotype C (hyperandrogenism plus polycystic ovaries) does not require irregular periods. Some women with regular bleeding are also anovulatory (cycle bleeds without ovulation), which can be confirmed with a mid-luteal progesterone test. Lean PCOS phenotypes also frequently present with regular cycles but elevated androgens.

Is PCOS genetic?

PCOS clusters strongly in families. Twin studies show 70 to 80 percent heritability. Specific genes (DENND1A, FSHR, THADA, INSR) have been implicated, but environmental factors — diet, weight, stress, sleep, gut microbiome — strongly modulate how the genetic predisposition expresses itself.

Does PCOS go away after menopause?

Some PCOS symptoms (hyperandrogenism, irregular cycles) ease with menopause as ovarian androgen production declines. The metabolic features — insulin resistance, elevated cardiovascular risk — persist and may worsen. Women with PCOS need cardiometabolic monitoring through and beyond menopause.

Sources

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility. 2023;120(4):767-793. PubMed: 37580056
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19-25. PubMed: 14711538
3. Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nature Reviews Disease Primers. 2016;2:16057. PubMed: 27510637
4. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016;106(1):6-15. PubMed: 27233760
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. 2018;131(6):e157-e171. PubMed: 29794677
6. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews. 2012;33(6):981-1030. PubMed: 23065822
7. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2017;32(5):1075-1091. PubMed: 28333286
8. NIH National Institute of Child Health and Human Development. Polycystic Ovary Syndrome (PCOS). NIH NICHD

Continue learning on PCOS Meal Planner

• Inositol vs Metformin for PCOS
• The PCOS Grocery List
• PCOS Breakfast Ideas
• Zinc for PCOS
• Semaglutide and PCOS
• About PCOS Meal Planner
• Our Editorial Standards

How this article was researched

This pillar guide was built from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, the 2003 Rotterdam Consensus, the ACOG 2018 Practice Bulletin, the 2016 Nature Reviews Disease Primers paper on PCOS, and primary epidemiology and mechanism papers in PubMed-indexed journals. This article is being prioritized for medical review by our contracted Registered Dietitian Nutritionist as part of our retroactive review program. See our editorial standards.